Skip to main content
Real-world study supports tocilizumab as first-line biologic in DMARD-IR patients with RA
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Real-world study supports tocilizumab as first-line biologic in DMARD-IR patients with RA
User login
Username
Password
Reset your password
Concept
Lead
score
Rheumatoid Arthritis
1
1
Disease-Modifying Antirheumatic Drugs
0
1
Biologic Therapy
0
1
Arthritis
0
0.27
Remission
0
0.13
Patient Safety
0
0.1
Specialty
Lead
score
Rheumatology
1
1
Pharmacist
0
1
Orthopaedics
0
0.3
Edit Tags